查詢結果分析
相關文獻
- A Single Institution Case Series of Patients with NK/T-cell Lymphoma
- Prognostic Factors in Node-Negative Breast Cancer Patients: The Experience in Taiwan
- Postoperative Radiotherapy of Adult Supratentorial High-grade Astrocytoma
- 成人低惡性度顱內星狀細胞瘤之術後放射治療
- Detection of Serum Anti-p53 Antibody in Patients with Renal Cell Carcinoma
- 乳癌預後因子探討--論流式細胞分析儀在乳癌之應用
- Prognostic Factors and Results of Radiotherapy for Brain Stem Gliomas
- Prognostic Value of DNA Ploidy Patterns of Colorectal Adenocarcinoma
- Anastomosis Leakage after Curative Resection for Mid and Low Rectal Cancer: A Poor Prognostic Factor?
- Radiation Therapy in Extranodal Non-Hodgkin's Lymphoma of the Head and Neck
頁籤選單縮合
題名 | A Single Institution Case Series of Patients with NK/T-cell Lymphoma=自然殺手/T細胞淋巴癌:單中心病例系列報告 |
---|---|
作者姓名(中文) | 蔡牧宏; 鄭詠仁; 郭瑾; 楊明維; 薛尉廷; 陳海雯; 林逢嘉; 蔡牧宏; | 書刊名 | 放射治療與腫瘤學 |
卷期 | 24:4 2017.12[民106.12] |
頁次 | 頁269-278 |
分類號 | 415.6 |
關鍵詞 | 淋巴癌; 預後; NK/T細胞淋巴癌; 預後因子; 生存; NK/T細胞預後指數; Lymphoma; Prognosis; NK/T cell lymphoma; Prognostic factors; Survival; Natural Killer/T-cell lymphoma prognostic index; NKPI; |
語文 | 英文(English) |
中文摘要 | 目的:回顧本院治療 NK/T 細胞淋巴癌之成果,並釐清預後因子對整體存活、疾病進展、與局 部控制的影響。 材料與方法:我們針對本院 2000-2014 年治療之所有 NK/T 細胞淋巴癌病人做一回溯性病歷分 析。病人至少需在本院接受一線的治療。我們從病歷資料中提取病人基本資訊、相關醫療記 錄、治療細節,與其治療成果。統計方面,我們採用 Kaplan-Meier 法估算整體存活、無進展存 活、與無局部區域復發存活,並以 Cox 比例風險模式分析預後因子對治療成果的差異。 結果:研究總計收錄 21 位病人,其中 12(57%)位分期為第 I-II 期、9(43%)位為第 IV 期。 所有病人之中位整體存活為 2 年。早期病人之中位存活(3.8 年)顯著較晚期病人為長(2.5 個 月)。在早期病人中,NK/T 淋巴癌預後指標(NKPI)與整體存活有顯著相關;有淋巴結侵犯的 病人,其局部復發的機率有較低的趨勢(P= 0.05, HR= 0.17)。 結論:與過去文獻報告相仿,NK/T 細胞淋巴癌的表現相當惡性,其預後不甚理想。提高未來治 療成效的策略包含:確實找出高風險的族群、使用較新的化學治療藥物、或提高放射線劑量。 |
英文摘要 | Purpose : We aim to review treatment outcomes at our institution and evaluate prognostic factors that influence overall survival, progression, and local recurrence. Material and Methods : We conducted a retrospective chart review of all patients with NK/T-cell lymphoma treated from 2000-2014 at our institution. Patients must have received at least one line of therapy. Baseline characteristics and treatment information were extracted from medical records. We employed the Kaplan-Meier product limit method to estimate loco-regional recurrence-free survival (LRFS), progression-free survival (PFS) and overall survival (OS). Cox proportional hazards models were used to assess significance of prognostic factors on treatment outcomes. Results : A total of 21 patients were included, of which 12 (57%) were stage I-II, while the other 9 (43%) were stage IV. Median overall survival for all patients was 2 years. Median survival was significantly longer for stage I-II (3.8 years) than stage IV (2.5 months). In early stage patients, the Natural Killer/T-Cell Lymphoma Prognostic Index (NKPI) was associated with overall survival; patients with clinically positive lymph nodes had a trend towards lower risk of local recurrence (P= 0.05, HR= 0.17). Conclusions : Treatment outcomes of NK/T-cell lymphoma suggest an aggressive pattern and poor outcome, comparable with reports in the literature. Identification of high-risk subgroups and aggressive treatment with modern chemotherapeutic agents, and/or radiotherapy dose escalation may be warranted to improve treatment outcomes. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。